I’ve named my pain management medication combos that get me through my #chemotherapy cycles of #paclitaxel + #carboplatin.
Tramadol Sandwich for general join pains staggered throughout the day (1000mg paracetamol taken with 50mg tramadol)
Not M&Ms for acute pain when necessary (200mg ibuprofen)
This multicenter phase 3 #ClinicalTrial demonstrated that #Socazolimab plus #Carboplatin and #Etoposide significantly improves survival in extensive-stage small cell lung cancer, offering a potent first-line immunochemotherapeutic option.
#OpenAccess: doi.org/10.1038/s413...
En mujeres c/CA mama HER2+ estadio II y III, taxanes + trastuzumab/pertuzumab s/carboplatino proporciona resp patológica completa sin diferencia a adición de carboplatino y mejora tolerabilidad, puede omitirse carboplatino #breast #cancer #carboplatin ascopubs.org/doi/full/10....
Agregar carboplatino a QT c/epirrubicina, ciclofosfamida y taxanes mejora supervivencia libre de enfermedad y general en pacientes c/CA mama triple negativo temprano, y aunque aumenta la toxicidad hematológica no surgen nuevas señales de seguridad #carboplatin #tnbc ascopubs.org/doi/full/10....
At #SABCS2025, Brooke M. Felsheim presented a pooled analysis of three major randomized trials - #BrighTNess, #CALGB40603, and #GeparSixto—providing one of the most comprehensive evaluations to date of #carboplatin in early-stage triple-negative breast cancer (TNBC).
🧮Calculate Carboplatin Dose using Wright Equation in 20 seconds with
@ONCOassist
#ONCOassist #WrightEquation #Carboplatin #GFR #OncologyTools #DigitalHealth #ClinicalCalculator #OncologyApp #ChemotherapyDosing #RenalFunction
🧮Calculate Carboplatin Dose using Cockcroft-Gault in 20 seconds with ONCOassist
#ONCOassist #Carboplatin #GFR #CockcroftGault #ChemoDosing #OncologyTools #DigitalHealth #ClinicalCalculator #OncologyApp #AUCdosing #CancerTreatment
Induction with #etoposide and #carboplatin (EC), followed by #camrelizumab, apatinib and EC, and then maintenance with #camrelizumab and apatinib shows promising #antitumor activity in #ESSCLC. #medsky
#STTT #OpenAccess: doi.org/10.1038/s413...
This study establishes HN1L as a promising #diagnosticbiomarker and therapeutic target, and suggests that targeting HN1L may offer an effective combination strategy with #carboplatin to overcome #PlatinumResistance in #Ovariancancer. #medsky
#OpenAccess: www.sciencedirect.com/science/arti...
Study S2312
S2312 is a study for people with castrate-resistant #prostatecancer. It tests a combination of chemo drugs, #carboplatin and #cabazitaxel.
SWOG.org/S2312. Or call 1-800-4-CANCER. Ask about S2312. #pcsm
Excess dosing of #carboplatin may occur when the Cockcroft-Gault equation is used for dosing, causing adverse events. #cockcroftgault #nephrology #oncology www.docwirenews.com/post/effect-...
🚀 Key #UrothelialCancer abstracts from #ASCOGU!
📌 Abstract 661 – #Durvalumab (#MEDI4736) + neoadjuvant chemo (#Gemcitabine + #Cisplatin / #Carboplatin) in high-risk upper tract urothelial carcinoma.
📌 Abstract 667 – #Durvalumab + intravesical #Gemcitabine & #Docetaxel in #BCG-unresponsive NMIBC.
5 papers about Lung Cancer suggested by Stephen Liu
@stephenvliu.bsky.social
oncodaily.com/science/step...
#Atezolizumab #Cancer #Carboplatin #Etoposide #Medicine #Health #LungCancer #LCSM #Nivolumab #NSCLC #Olaparib #OncoDaily #Oncology #SCLC #Temozolomide
S2312: A research study for people with castrate-resistant prostate cancer
S2312 is a study for people with castrate-resistant #prostatecancer. It tests a combination of
chemo drugs, #carboplatin and #cabazitaxel. Visit SWOG.org/S2312. Or call 1-800-4-CANCER. Ask
about S2312. #pcsm